Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies
Am J Bioeth
.
2018 Aug;18(8):3-6.
doi: 10.1080/15265161.2018.1489653.
Authors
Jeremy Sugarman
1
,
Supriya Shivakumar
2
,
Martha Rook
2
,
Jeanne F Loring
3
,
Christoph Rehmann-Sutter
4
,
Jochen Taupitz
5
,
Jutta Reinhard-Rupp
6
,
Steven Hildemann
7
Affiliations
1
a Berman Institute of Bioethics, Johns Hopkins University.
2
b MilliporeSigma.
3
c The Scripps Research Institute.
4
d Institute for History of Medicine and Science Studies, University of Lübeck.
5
e Institute for German, European and International Medical Law, Public Health Law and Bioethics of the Universities of Heidelberg and Mannheim.
6
f Merck Global Health Institute.
7
g University Clinic for Cardiology and Angiology, University Heart Center, University of Freiburg, and Merck KGaA.
PMID:
30133390
DOI:
10.1080/15265161.2018.1489653
No abstract available
MeSH terms
Bioethical Issues
Commerce / ethics*
Gene Editing / ethics*
Genetic Therapy / ethics*
Humans
Reproductive Techniques / ethics